Balimbingan, Virginia B.

HRN: 24-57-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/10/2024
10/25/2024
IV
600mg
Qid
Gangrenous Dm Foot Ulcer
Waiting Final Action 
10/10/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/10/2024
10/25/2024
IV
4.5gm
Qid
Sepsis
Waiting Final Action 
10/22/2024
CO-AMOXICLAV 625MG (TAB)
10/22/2024
10/26/2024
ORAL
625 Mg
Every 8 Hours
S/P AKA
Waiting Final Action 
10/22/2024
CLINDAMYCIN 300MG (CAP)
10/22/2024
10/26/2024
ORAL
300mg
Every 8 Hours
S/P AKA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: